Signs of acid reflux after gastric sleeve surgery are experienced by a significant number of patients and can range from mild heartburn to more serious complications requiring medical review. Gastric sleeve surgery (sleeve gastrectomy) reshapes the stomach into a narrow tube, which can increase intragastric pressure and disrupt the anti-reflux barrier, predisposing some patients to gastro-oesophageal reflux disease (GORD). Recognising symptoms early — and understanding when to seek help — is essential for protecting your long-term digestive health. This article explains why reflux occurs, what to look out for, and the treatment options available on the NHS.

Why Acid Reflux Can Develop After Gastric Sleeve Surgery

Gastric sleeve surgery increases intragastric pressure and disrupts the anti-reflux barrier — including the lower oesophageal sphincter and angle of His — making acid reflux and GORD more likely post-operatively.

Gastric sleeve surgery, formally known as sleeve gastrectomy, involves removing approximately 75–80% of the stomach to create a narrow, tube-shaped pouch. While this procedure is highly effective for weight loss, it can significantly alter the mechanics of the upper digestive tract in ways that predispose some patients to gastro-oesophageal reflux disease (GORD).

One of the primary reasons acid reflux develops after a gastric sleeve is the reduction in the stomach's capacity to act as a reservoir. The smaller, tubular stomach generates higher intragastric pressure, which can force stomach acid upwards into the oesophagus. The surgery may also alter the anti-reflux barrier — including the angle of His, hiatal integrity, and the sling fibres of the lower oesophageal sphincter (LOS) — reducing its effectiveness at preventing acid from travelling back up. In addition, bile reflux and changes in sleeve morphology, such as torsion or narrowing at the incisura (incisural stenosis), can contribute to symptoms in some patients.

Removal of the gastric fundus reduces the stomach's compliance, meaning pressure builds more readily after eating. Some patients who had no reflux symptoms before surgery find that GORD develops or worsens post-operatively, a pattern that has been well-documented in bariatric surgical literature and acknowledged by the British Obesity and Metabolic Surgery Society (BOMSS).

Pre-existing hiatus hernia — where part of the stomach pushes through the diaphragm — is a known risk factor for post-sleeve reflux. Surgeons will typically assess for this before the procedure; where a hiatus hernia is identified, concomitant repair at the time of sleeve gastrectomy is often performed and may reduce the risk of postoperative reflux. The presence of significant or symptomatic hiatus hernia may also influence whether a gastric sleeve or an alternative such as a Roux-en-Y gastric bypass is recommended. NICE NG1 provides the overarching UK framework for the investigation and management of GORD in adults.

Common Signs and Symptoms to Be Aware Of

Key signs include heartburn, regurgitation, dysphagia, hoarseness, persistent cough, nausea, and dental erosion; silent reflux may present with only throat clearing or a sensation of something stuck in the throat.

Recognising the signs of acid reflux after gastric sleeve surgery is important for timely management and to prevent longer-term complications. Symptoms can range from mild and intermittent to persistent and disruptive, and they may appear weeks, months, or even years after the operation.

The most frequently reported symptoms include:

• Heartburn — a burning sensation in the chest or throat, often worse after eating or when lying down

• Regurgitation — the sensation of acid or partially digested food rising into the mouth or throat

• Dysphagia — difficulty or discomfort when swallowing (see below regarding when to seek urgent advice)

• Odynophagia — pain on swallowing

• Persistent cough or hoarseness — caused by acid irritating the larynx and airways, particularly at night

• Bloating or excessive belching — particularly after meals

• Nausea — which may be mistaken for other post-operative symptoms

• A sour or bitter taste in the mouth, especially in the morning

• Chest or epigastric pain

• Dental enamel erosion — from repeated acid exposure in the mouth

Some patients experience what is known as silent reflux (laryngopharyngeal reflux), where acid reaches the throat and voice box without producing the classic heartburn sensation. This can make diagnosis more challenging, as patients may only notice throat clearing, a persistent cough, or a feeling of something stuck in the throat. It is worth noting that these symptoms can also be caused by other conditions such as asthma or post-nasal drip, so assessment by a clinician is important.

It is also important to distinguish reflux symptoms from other post-bariatric complications such as sleeve stricture or stenosis (for example, narrowing at the incisura), staple line leaks, or dumping syndrome, all of which can present with overlapping symptoms. If you are unsure whether your symptoms represent acid reflux or another issue, contacting your bariatric team for assessment is always the appropriate first step. Keeping a symptom diary — noting timing, food triggers, and severity — can be a helpful tool when discussing your concerns with a clinician.

When to Seek Medical Advice or Contact Your Surgical Team

Dysphagia, vomiting blood, black tarry stools, or severe chest pain require urgent assessment; heartburn occurring more than twice weekly or poorly controlled by antacids warrants prompt GP or bariatric team review.

Not all post-operative digestive discomfort requires urgent attention, but certain symptoms should prompt you to seek medical advice promptly. Understanding when to escalate your concerns can make a meaningful difference to your health outcomes.

Contact your GP or bariatric surgical team if you experience:

• Heartburn or regurgitation that occurs more than twice a week

• Symptoms that are not adequately controlled with over-the-counter antacids or alginates

• Unintentional weight loss beyond your expected post-operative trajectory

• Persistent nausea or vomiting

• Worsening symptoms despite dietary modifications

Seek an urgent appointment or urgent referral (2-week-wait pathway) if you experience:

• Any difficulty swallowing (dysphagia) — this warrants urgent assessment under the suspected cancer pathway per NICE NG12, as it is considered an alarm symptom

• Unexplained iron-deficiency anaemia

• Persistent vomiting alongside unintentional weight loss

Seek urgent medical attention (via A&E or 999) if you notice:

• Vomiting blood or material that resembles coffee grounds

• Black, tarry stools, which may indicate gastrointestinal bleeding

• Severe chest pain (to rule out cardiac causes)

• Signs of dehydration such as dizziness, reduced urine output, or extreme fatigue

Untreated chronic acid reflux can lead to serious complications, including oesophagitis (inflammation of the oesophageal lining), Barrett's oesophagus (a pre-cancerous change in the oesophageal cells), and in rare cases, oesophageal adenocarcinoma. NICE NG12 highlights the importance of investigating alarm symptoms of upper gastrointestinal disease without delay, and NICE NG1 provides guidance on the investigation and management of GORD and dyspepsia in adults.

Your bariatric team will typically offer follow-up appointments at regular intervals after surgery. It is essential to attend these reviews and to raise any new or worsening symptoms, even if they seem minor. Early intervention is far more effective than managing complications that have been allowed to progress.

Treatment and Management Options Available on the NHS

NHS management follows NICE NG1 and includes lifestyle changes, alginate preparations, and PPIs such as omeprazole; severe refractory cases may require surgical revision to Roux-en-Y gastric bypass.

The management of acid reflux following gastric sleeve surgery is guided by symptom severity, investigation findings, and individual patient factors. The NHS offers a range of treatment options, from lifestyle modifications through to surgical revision in refractory cases.

Lifestyle and dietary measures are usually the first line of management and include:

• Eating smaller, more frequent meals and chewing food thoroughly

• Avoiding trigger foods such as fatty or spicy foods, caffeine, alcohol, and carbonated drinks

• Not lying down for at least two to three hours after eating

• Elevating the head of the bed by 15–20 cm

• Maintaining a healthy weight and avoiding tight-fitting clothing

• Stopping smoking, which impairs the anti-reflux barrier and worsens symptoms

Pharmacological treatment is commonly prescribed alongside lifestyle changes, in line with NICE NG1:

• Alginate-based preparations (such as sodium alginate combined with an antacid) are recommended by NICE NG1 as an adjunct or on-demand option. They work by forming a physical barrier (raft) on top of stomach contents, helping to prevent acid from reaching the oesophagus, and are available over the counter or on prescription.

• Proton pump inhibitors (PPIs) such as omeprazole or lansoprazole are the mainstay of medical therapy for more persistent symptoms. They work by blocking the hydrogen-potassium ATPase enzyme system in the gastric parietal cells, thereby reducing acid secretion. For best effect, PPIs should be taken 30–60 minutes before a meal. Response should be reviewed at 4–8 weeks; if symptoms are not adequately controlled, dose escalation may be considered before switching agents. PPIs are available on NHS prescription and are generally well tolerated. However, long-term use should be reviewed periodically by a clinician, as established risks include increased susceptibility to Clostridioides difficile infection, hypomagnesaemia, reduced bone density (fracture risk), vitamin B12 deficiency, and effects on kidney function, as highlighted in MHRA Drug Safety Updates and the relevant Summary of Product Characteristics (SmPC). PPIs should not be stopped abruptly without medical advice, as rebound acid hypersecretion can occur. If you experience a suspected side effect from any medication, you can report it via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk.

• H2 receptor antagonists such as famotidine may be used as an adjunct or alternative in some patients. Note that ranitidine has been withdrawn from the UK market; cimetidine carries significant drug interaction risks and is rarely used in current practice.

If symptoms persist despite optimal medical therapy, further investigation may be arranged through your gastroenterology or bariatric team. This may include upper GI endoscopy, contrast swallow (to assess sleeve anatomy, stricture, or hiatal hernia), oesophageal pH-impedance monitoring, or oesophageal manometry in selected cases.

In cases where reflux is severe and unresponsive to conservative measures, surgical revision may be considered. Options include Roux-en-Y gastric bypass — which reduces acid exposure and diverts bile away from the oesophagus, significantly improving reflux in appropriately selected patients — and hiatal hernia repair where anatomical factors are contributing. These decisions are made collaboratively within the multidisciplinary bariatric team.

Long-Term Outlook and Reducing Your Risk of Complications

Most patients achieve good symptom control with diet, medication, and regular follow-up; conversion to Roux-en-Y gastric bypass remains available for those with chronic, unmanageable reflux.

The long-term outlook for patients experiencing acid reflux after gastric sleeve surgery is generally positive when symptoms are identified early and managed appropriately. Many patients achieve good symptom control through a combination of dietary adjustments and medication, allowing them to maintain the weight loss benefits of their surgery without significant impact on quality of life.

However, it is important to remain vigilant over the longer term. Evidence suggests that a meaningful proportion of patients who undergo sleeve gastrectomy will develop new-onset or worsening GORD in the years following surgery, and symptoms can sometimes emerge several years after the procedure.

Regular follow-up is an important part of post-bariatric care. In line with NHS England service specifications and BOMSS guidance, specialist follow-up is typically provided for up to two years after surgery, after which ongoing annual monitoring is usually transferred to primary care. These reviews provide an opportunity to monitor symptoms, review medication, check nutritional status, and arrange investigations if needed. It is important to attend all scheduled appointments and to raise any new or changing symptoms promptly.

If Barrett's oesophagus is diagnosed as a result of investigations, surveillance will be arranged in accordance with British Society of Gastroenterology (BSG) guidelines.

Practical steps to reduce your long-term risk include:

• Adhering to the dietary guidance provided by your bariatric dietitian

• Taking prescribed medications consistently and not stopping PPIs without medical advice

• Attending all scheduled follow-up appointments

• Reporting any new or changing symptoms promptly

• Avoiding smoking, which weakens the anti-reflux barrier and worsens reflux

• Limiting alcohol intake, which can irritate the oesophageal lining

For patients in whom reflux becomes a chronic, unmanageable problem, conversion to a Roux-en-Y gastric bypass remains a well-established and effective option within NHS bariatric services. This decision is made collaboratively between the patient and their multidisciplinary team, taking into account overall health, weight loss goals, and symptom burden.

In summary, while acid reflux is a recognised complication of gastric sleeve surgery, it is manageable with the right support. Staying informed, maintaining open communication with your healthcare team, and acting promptly on new symptoms are the most effective ways to protect your long-term digestive health and overall wellbeing.

Frequently Asked Questions